Hayakawa, Fumihiko
Nagoya University
4 papers on CoChatORCID 0000-0002-6067-6382
Most cited papers
- Verified
A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases
Hayakawa, F., Sugimoto, K., Harada, Y., Hashimoto, N., Ohi, N., Kurahashi, S., & Naoe, T. (2013) · Blood Cancer Journal
Cytokine Signaling Pathways and InteractionsAcute Myeloid Leukemia Research
Cited by 108
- Verified
Biology and management of primary effusion lymphoma
Shimada, K., Hayakawa, F., & Kiyoi, H. (2018) · Blood
Viral-associated cancers and disordersLymphoma Diagnosis and Treatment
Cited by 103
- Verified
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma
Kunou, S., Shimada, K., Takai, M., Sakamoto, A., Aoki, T., Hikita, T., Kagaya, Y., Iwamoto, E., Sanada, M., Shimada, S., et al. (2021) · Oncogene
Extracellular vesicles in diseaseMicroRNA in disease regulation
Cited by 62
- Verified
Response of SMRT (Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor) and N-CoR (Nuclear Receptor Corepressor) Corepressors to Mitogen-Activated Protein Kinase Kinase Kinase Cascades Is Determined by Alternative mRNA Splicing
Jonas, B. A., Varlakhanova, N., Hayakawa, F., Goodson, M., & Privalsky, M. L. (2007) · Molecular Endocrinology
RNA Research and SplicingEstrogen and related hormone effects
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free